InsideTumorCells: Cancer therapy with reduced systemic exposure and release of the drug into tumour cells (Q2866735)

From EU Knowledge Graph
Revision as of 01:07, 7 July 2021 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in en: translated_label)
Jump to navigation Jump to search
Project Q2866735 in Portugal
Language Label Description Also known as
English
InsideTumorCells: Cancer therapy with reduced systemic exposure and release of the drug into tumour cells
Project Q2866735 in Portugal

    Statements

    country
    Portugal
    0 references
    budget
    42,500.0 Euro
    0 references
    co-financing rate
    76.0 percent
    0 references
    start time
    18 June 2019
    0 references
    end time
    15 February 2022
    0 references
    beneficiary name (string)
    UNIVERSIDADE DE COIMBRA
    0 references
    coordinate location

    40°12'40.28"N, 8°25'46.06"W
    0 references
    summary
    InsideTumorCells pretende proteger por patente os direitos de PI de um novo medicamento para o cancro que liberta o fármaco dentro das células tumorais, minimizando os efeitos secundários. (Portuguese)
    0 references
    InsideTumorCells intends to patently protect the IP rights of a new cancer medicine that releases the drug into tumour cells, minimising side effects. (English)
    point in time
    7 July 2021
    0 references
    location (string)
    Coimbra
    0 references

    Identifiers

    Portuguese Kohesio ID
    CENTRO-01-0145-FEDER-042773
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q2866735&oldid=10655511"